Contact Us

SEC Filings

Investor Contacts

Andrea N. Flynn, Ph.D.
Vice President, Head,
Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 3211
U.S.: +1 650 496 2717

SEC Filings

Filing date	Form	Description	Filing Group	View
Jan 18, 2012	3	Initial filing by director officer or owner of more than ten percent.	3,4,5	View HTML 0001209191-12-004341.pdf 0001209191-12-004341.rtf
May 31, 2007	3	Initial filing by director officer or owner of more than ten percent.	3,4,5	View HTML 0001181431-07-036466.pdf 0001181431-07-036466.rtf
May 31, 2007	3	Initial filing by director officer or owner of more than ten percent.	3,4,5	View HTML 0001181431-07-036567.pdf 0001181431-07-036567.rtf
Dec 09, 2009	3	Initial filing by director officer or owner of more than ten percent.	3,4,5	View HTML 0001232524-09-000031.pdf 0001232524-09-000031.rtf
May 31, 2007	3	Initial filing by director officer or owner of more than ten percent.	3,4,5	View HTML 0001181431-07-036461.pdf 0001181431-07-036461.rtf
May 09, 2013	3	Initial filing by director officer or owner of more than ten percent.	3,4,5	View HTML 0001232524-13-000037.pdf 0001232524-13-000037.rtf
May 09, 2013	3	Initial filing by director officer or owner of more than ten percent.	3,4,5	View HTML 0001232524-13-000038.pdf 0001232524-13-000038.rtf
May 09, 2013	3	Initial filing by director officer or owner of more than ten percent.	3,4,5	View HTML 0001232524-13-000039.pdf 0001232524-13-000039.rtf
Mar 14, 2014	3	Initial filing by director officer or owner of more than ten percent.	3,4,5	View HTML 0001232524-14-000031.pdf 0001232524-14-000031.rtf
Aug 07, 2014	3	Initial filing by director officer or owner of more than ten percent.	3,4,5	View HTML 0001232524-14-000085.pdf 0001232524-14-000085.rtf

Data provided by Kaleidoscope.